BIO Protocol Expands to Solana: What This Means for DeSci
- BIO will soon launch on the Solana blockchain, confirmed founder Paul Kohlhaas.
- As of November, the DeSci project has raised a massive $33 million.
- BIO Protocol will participate in the JP Morgan Healthcare Conference next month.
BIO Protocol, a Binance Labs-backed decentralized science (DeSci) project, is expanding to Solana. Leveraging Solana’s scalability and low fees, this move could revolutionize the DeSci market. With $33 million in funding, BIO Protocol aims to transform how early-stage scientific research is funded and commercialized.
Expanding Beyond Ethereum
Currently operating on Ethereum with seven “BioDAOs,” BIO Protocol is broadening its reach by expanding to Solana and other blockchains. This launch highlights the growing potential of Solana’s ecosystem in driving innovation in DeSci.
The protocol focuses on researching cryopreservation, women’s health, and psychedelics for mental health. It plans to expand research initiatives to chronic diseases and COVID. BIO Protocol’s founder and CEO, Paul Kohlhaas, announced the Solana launch on X, hinting at potential airdrops to major pharmaceutical companies.
BIO Protocol will also part…
The post BIO Protocol Expands to Solana: What This Means for DeSci appeared first on Coin Edition.
Read More
BIO Protocol Expands to Solana: What This Means for DeSci
- BIO will soon launch on the Solana blockchain, confirmed founder Paul Kohlhaas.
- As of November, the DeSci project has raised a massive $33 million.
- BIO Protocol will participate in the JP Morgan Healthcare Conference next month.
BIO Protocol, a Binance Labs-backed decentralized science (DeSci) project, is expanding to Solana. Leveraging Solana’s scalability and low fees, this move could revolutionize the DeSci market. With $33 million in funding, BIO Protocol aims to transform how early-stage scientific research is funded and commercialized.
Expanding Beyond Ethereum
Currently operating on Ethereum with seven “BioDAOs,” BIO Protocol is broadening its reach by expanding to Solana and other blockchains. This launch highlights the growing potential of Solana’s ecosystem in driving innovation in DeSci.
The protocol focuses on researching cryopreservation, women’s health, and psychedelics for mental health. It plans to expand research initiatives to chronic diseases and COVID. BIO Protocol’s founder and CEO, Paul Kohlhaas, announced the Solana launch on X, hinting at potential airdrops to major pharmaceutical companies.
BIO Protocol will also part…
The post BIO Protocol Expands to Solana: What This Means for DeSci appeared first on Coin Edition.
Read More